Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amanda Yunker, D.O.
Vanderbilt Medical Center
Principal Investigator - Aytekin Oto, MD
University of Chicago, Chicago, Illinois, United States
Principal Investigator - Elizabeth David, MD
Sunnybrook Health Sciences Center, Toronto, Ontario, Canada
Principal Investigator - Hyo Keun Lim, MD
Samsung Medical Center, Seoul, Republic of Korea
Principal Investigator - John H Fischer II, MD
St. Luke's Episcopal Hospital, Houston, Texas, United States
Principal Investigator - Peter Liu, M.D.
University of Michigan
Principal Investigator - Rajiv Chopra, PhD
University of Texas Southwestern Medical Center
Principal Investigator - Robert K Zurawin, MD
St. Luke's Episcopal Hospital, Houston, Texas, United States
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Samsung Medical Center
Seoul, South Korea
- University of Chicago
Chicago, Illinois, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Oregon Science and Health University
Portland, Oregon, United States
- Vanderbilt Medical Center
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- St. Luke'S Episcopal Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2012
- Primary completion
- 31 Mar 2016
- Completion
- 31 Mar 2016
- Last update posted
- 5 Apr 2017
- Registered enrollment
- 49
- Registry id
- NCT01504308
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.